Gennova Biopharma seeks DCGI approval for its Omicron booster

A person in the know informed sources that Gennova Biopharmaceuticals, a subsidiary of Pune-based drugmaker Emcure, has filed data for its mRNA-based Omicron specific Covid-19 booster shot for approval to the drug regulator, despite an increase...

Stakeboat Capital provides Rs. 50 crore in Series-A funding to Sukino Healthcare Solutions

Sukino Healthcare Solutions, India's first comprehensive continuum of care provider for long-term healthcare management, has received a Rs. 50 crore Series-A private equity investment from Stakeboat Capital...

California, drugmaker collaborates to produce affordable insulin

The state of California and a generic drug manufacturer announced a 10-year partnership Saturday to produce affordable, state-branded insulin that they hope will rival longtime producers and push down prices for a medication used by millions of....

Impact of Smart Packaging on Pharmaceutical Industry

In today's world, product safety has become a key priority for the pharmaceutical industry. As such, the use of smart packaging and related technologies has become increasingly important.

OKYO Pharma reports phase 2 trial of OK-101 drug to treat dry eye disease is now listed on ClinicalTrials.gov public website

OKYO Pharma Limited, an ophthalmology-focused bio-pharmaceutical company developing OK-101 to treat dry eye disease (DED) in order to address the significant unmet need in this multibillion-dollar market, announced that its planned trial...

Dr Reddy's sells 9 dermatology trademarks to Eris for Rs 2,750 million

Eris Lifesciences Limited has revealed the purchase of nine dermatology brands from Dr Reddy's Laboratories for a total of Rs 2,750 million. The majority of the products are in cosmetology categories such as anti-acne, moisturisers, cleansers,...

© 2023 India Pharma Outlook. All Rights Reserved.